Global law firm White & Case LLP has advised leading global investment firm EQT on its sale of portfolio company Karo Healthcare, one of Europe’s leading consumer health platforms, to KKR.
EQT is an investment organization with €269 billion in assets under management in two business segments – private capital and real assets. It owns portfolio companies and assets in Europe, Asia-Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership.
Since EQT’s initial investment in 2019, Karo has undergone a strategic repositioning, evolving from a Nordics-focused specialty pharmaceutical company into a pan-European pureplay consumer healthcare platform. It achieved revenue of €530 million during 2024 and its fully digitised platform reaches consumers in more than 90 markets.
The White & Case team which advised on the transaction was led by partner Patrik Erblad (Stockholm & London) and included partners Michael Weir, Michael Engel (both London), Philip Trillmich (London & Frankfurt), Johan Thiman, Oscar Liljeson, Rasmus Lüning (all Stockholm), Sara Nordin (Brussels & Stockholm) and Carlo Meert (Brussels) and associates Jonas Brandt, Olivia Engberg, Isak Bruncevic, Even Wiborg Nordsletten, Carl Brehmer, Denise Sparremo, Richard Martin, Matilda Högberg, Erik Holm (all Stockholm), Benedict Tansey, Serena Howard, Amelia Nichols (all London) and Aude Goffaux (Brussels).
Press contact
For more information please speak to your local media contact.
